Cervical CA 2018 FIGO Update (Part1): Revised Staging system.
Recent developments in imaging and increased use of minimally invasive surgery have changed the paradigm for diagnosis and management of cervical cancer. The FIGO Gynecologic Oncology Committee, in 2018, revised the Cervical Ca staging system based on these advances.
Imaging evaluation may now be used in addition to clinical examination where resources permit. The revised staging permits the use of any of the imaging modalities according to available resources, i.e. ultrasound, CT, MRI, positron emission tomography (PET), to provide information on tumor size, nodal status, and local or systemic spread. In this session, which is Part 1, we will review the pathogenesis, epidemiology, symptomatology, and 2018 FIGO revised cervical cancer staging system. We will leave management of cervical cancer for Part 2.
Imaging evaluation may now be used in addition to clinical examination where resources permit. The revised staging permits the use of any of the imaging modalities according to available resources, i.e. ultrasound, CT, MRI, positron emission tomography (PET), to provide information on tumor size, nodal status, and local or systemic spread. In this session, which is Part 1, we will review the pathogenesis, epidemiology, symptomatology, and 2018 FIGO revised cervical cancer staging system. We will leave management of cervical cancer for Part 2.
Activity